Present Evidence of Determinants to Predict the Efficacy of Renal Denervation

Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were in...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hypertension 2022-08, Vol.2022, p.1-12
Main Authors: Zhou, Hao, Xu, Yanping, Chen, Weijie, Wang, Liang, Du, Huaan, Liu, Hang, Ling, Zhiyu, Yin, Yuehui
Format: Article
Language:English
Subjects:
African Americans
Age
Analysis
Antihypertensive drugs
Antihypertensives
Blood pressure
Catheters
Clinical trials
Denervation
Heart rate
Hypertension
Nervous system
Obesity
Patient compliance
Patients
Review
Trends
Ultrasonic imaging
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were inconsistent and not all patients benefited from RDN. Appropriate patient selection and intraoperative factors to improve the efficacy of RDN need to be solved urgently. Over the decade, research studies on the correlations between indicators and the antihypertensive effects have been conducted and made a fairly well progress. Herein, we comprehensively reviewed the research studies on how to make RDN more predictable or improve the efficacy of RDN and summarized these potential indicators or devices which might be applied in clinical settings.
ISSN:2090-0384
2090-0392
2090-0392
DOI:10.1155/2022/5694127